Contrast Behavior Between Microadenoma and Normal Pituitary Gland After Gadolinium Injection as a Function of Time at 1.5 T

Neuroradiology - Germany
doi 10.1007/bf00596332
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Brain Gadolinium Deposition After Administration of Gadolinium-Based Contrast Agents

Japanese Journal of Radiology
Nuclear MedicineRadiologyImaging
2015English

High-Resolution MR Imaging of Pituitary Microadenomas at 1.5 T: Experience With Cushing Disease

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1989English

Contrast-Enhanced Whole Heart Coronary MRI With a Bolus Infusion of Gadobenate Dimeglumine at 1.5 T

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2010English

Pharmacokinetic Analysis for the Differentiation of Pituitary Microadenoma Subtypes Through Dynamic Contrast‑enhanced Magnetic Resonance Imaging

Oncology Letters
Cancer ResearchOncology
2019English

Contrast Optimization for the Detection of Focal Hepatic Lesions by MR Imaging at 1.5 T

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1987English

Enhancement of Liver and Pancreas on Late Hepatic Arterial Phase Imaging: Quantitative Comparison Among Multiple Gadolinium-Based Contrast Agents at 1.5 Tesla MRI

Journal of Magnetic Resonance Imaging
Nuclear MedicineRadiologyImaging
2013English

Real-Time Magnetic Resonance Imaging–Guided Cryoablation of Small Renal Tumors at 1.5 T

Investigative Radiology
MedicineNuclear MedicineRadiologyImaging
2013English

Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent

English

Neurosarcoidosis Presenting in the Pituitary Gland With Normal Endocrine Studies

Skull Base
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy